These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 27138078)
1. Role of Botulinum Toxin in Depression. Parsaik AK; Mascarenhas SS; Hashmi A; Prokop LJ; John V; Okusaga O; Singh B J Psychiatr Pract; 2016 Mar; 22(2):99-110. PubMed ID: 27138078 [TBL] [Abstract][Full Text] [Related]
2. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study. Magid M; Reichenberg JS; Poth PE; Robertson HT; LaViolette AK; Kruger TH; Wollmer MA J Clin Psychiatry; 2014 Aug; 75(8):837-44. PubMed ID: 24910934 [TBL] [Abstract][Full Text] [Related]
3. Treating depression with botulinum toxin: a pooled analysis of randomized controlled trials. Magid M; Finzi E; Kruger TH; Robertson HT; Keeling BH; Jung S; Reichenberg JS; Rosenthal NE; Wollmer MA Pharmacopsychiatry; 2015 Sep; 48(6):205-10. PubMed ID: 26252721 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Ketamine in Bipolar Depression: Systematic Review and Meta-analysis. Parsaik AK; Singh B; Khosh-Chashm D; Mascarenhas SS J Psychiatr Pract; 2015 Nov; 21(6):427-35. PubMed ID: 26554325 [TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin for the treatment of sialorrhea: a meta-analysis. Vashishta R; Nguyen SA; White DR; Gillespie MB Otolaryngol Head Neck Surg; 2013 Feb; 148(2):191-6. PubMed ID: 23112272 [TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of botulinum toxin for management of scars: A systematic review with meta-analysis and trial sequential analysis. Wang D; Qu J; Jiang H; Jiang Y Toxicon; 2019 Aug; 166():24-33. PubMed ID: 31047933 [TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. Jackson JL; Kuriyama A; Hayashino Y JAMA; 2012 Apr; 307(16):1736-45. PubMed ID: 22535858 [TBL] [Abstract][Full Text] [Related]
8. [Botulinum toxin for the treatment of major depressive disorder]. Hawlik AE; Freudenmann RW; Pinkhardt EH; Schönfeldt-Lecuona CJ; Gahr M Fortschr Neurol Psychiatr; 2014 Feb; 82(2):93-9. PubMed ID: 24519192 [TBL] [Abstract][Full Text] [Related]
9. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials. Berlim MT; Van den Eynde F; Daskalakis ZJ J Clin Psychiatry; 2013 Feb; 74(2):e122-9. PubMed ID: 23473357 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of Botulinum Toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach. Baker JA; Pereira G Clin Rehabil; 2013 Dec; 27(12):1084-96. PubMed ID: 23864518 [TBL] [Abstract][Full Text] [Related]
11. Obesity Treatment with Botulinum Toxin-A Is Not Effective: a Systematic Review and Meta-Analysis. Bustamante F; Brunaldi VO; Bernardo WM; de Moura DTH; de Moura ETH; Galvão M; Santo MA; de Moura EGH Obes Surg; 2017 Oct; 27(10):2716-2723. PubMed ID: 28812212 [TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of botulinum toxin versus non-surgical treatments for treating lateral epicondylitis: a systematic review and meta-analysis. Lin YC; Wu WT; Hsu YC; Han DS; Chang KV Clin Rehabil; 2018 Feb; 32(2):131-145. PubMed ID: 28349703 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of botulinum toxin type A in distraction osteogenesis of the lower extremities: a meta-analysis of randomized controlled trials. Su YC; Guo YH; Hsieh PC; Lin YC BMC Musculoskelet Disord; 2022 Mar; 23(1):286. PubMed ID: 35337325 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trials. Arnone D; Galadari H; Rodgers CJ; Östlundh L; Aziz KA; Stip E; Young AH J Psychopharmacol; 2021 Aug; 35(8):910-918. PubMed ID: 33719696 [TBL] [Abstract][Full Text] [Related]
15. Glabellar Botulinum Toxin Injection Improves Depression Scores: A Systematic Review and Meta-Analysis. Crowley JS; Silverstein ML; Reghunathan M; Gosman AA Plast Reconstr Surg; 2022 Jul; 150(1):211e-220e. PubMed ID: 35588104 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials. Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252 [TBL] [Abstract][Full Text] [Related]